Moderna (MRNA) FCF Margin (2018 - 2026)
Moderna's (MRNA) quarterly FCF Margin came in at 170.95% in Q1 2026, up 89757.0% year-on-year from N/an in Q1 2025, and down 230.08% on a QoQ basis from 131.42% in Q4 2025.
Moderna (MRNA) FCF Margin (2018 - 2026) Analysis & Trends
Moderna (MRNA) has 9 years of FCF Margin data on file, last reported at 170.95% in Q1 2026.
- On a quarterly basis, FCF Margin rose 89757.0% year-over-year to 170.95% in Q1 2026; TTM through Mar 2026 was 70.83%, a 2580.0% increase from a year earlier, with the FY2025 full-year figure at 106.22%, down 1040.0% from the prior year.
- FCF Margin for Q1 2026 stood at 170.95%, down from 131.42% in the prior quarter.
- Over the last five years, FCF Margin for MRNA reached as high as 131.42% in Q4 2025 and fell as low as 1068.52% in Q1 2025.
- Historically, FCF Margin has averaged 202.22% across 5 years, with a median of 71.86% in 2023.
- Across the five-year window, FCF Margin tumbled 63772 bps in 2024 and soared 89757 bps in 2026, its largest moves.
- Year by year, FCF Margin stood at 30.88% in 2022, then slumped by 93 bps to 2.24% in 2023, then jumped by 3623 bps to 83.44% in 2024, then surged by 58 bps to 131.42% in 2025, then slumped by 230 bps to 170.95% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 170.95% in Q1 2026, 131.42% in Q4 2025, and 93.8% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Moderna | 22.52 Bn | 17.32 Bn | -566.00 Mn | -170.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -170.95% |
| Dec 31, 2025 | 131.42% |
| Sep 30, 2025 | -93.80% |
| Jun 30, 2025 | -597.89% |
| Mar 31, 2025 | -1,068.52% |
| Dec 31, 2024 | 83.44% |
| Sep 30, 2024 | -67.99% |
| Jun 30, 2024 | -604.15% |
| Mar 31, 2024 | -709.58% |
| Dec 31, 2023 | 2.24% |
| Sep 30, 2023 | -89.73% |
| Jun 30, 2023 | -263.66% |
| Mar 31, 2023 | -71.86% |
| Dec 31, 2022 | 30.88% |
| Sep 30, 2022 | 4.85% |
| Jun 30, 2022 | 3.14% |
| Mar 31, 2022 | 44.49% |
| Dec 31, 2021 | 45.28% |
| Sep 30, 2021 | 65.91% |
| Jun 30, 2021 | 92.31% |